GHENT, Belgium - Tuesday, 13. December 2022 AETOSWire Print
(BUSINESS WIRE)--MRM Health—a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics—today announced that its Type-2 Diabetes Program, developed in collaboration with IFF…